Orris

Congestive heart failure

Reading File
Finding Sources
Searching PubMed

"heart failure"[MeSH Terms] AND "management"[MeSH Terms]

Searching Images

congestive heart failure pathophysiology diagram

Reading File
Finding Sources
Searching Images

heart failure chest X-ray pulmonary edema cardiomegaly

This anterior-posterior (AP) chest X-ray illustrates classic radiological findings of acute congestive heart failure. The primary finding is significant cardiomegaly, with the cardiac silhouette appearing enlarged and globular, occupying more than 50% of the thoracic diameter. Diffuse, bilateral hazy opacities are present throughout both lung fields, consistent with pulmonary edema. These opacifications are most prominent in the perihilar regions and lung bases, obscuring normal pulmonary vasculature and the sharp definition of the diaphragmatic borders. The costophrenic angles appear blunted, suggesting associated pleural effusions. Visible medical hardware includes ECG leads positioned on the chest wall. The image serves as an educational example of how chronic heart failure with reduced ejection fraction manifests as pulmonary venous congestion and interstitial-to-alveolar edema on diagnostic imaging.

This anterior-posterior (AP) chest X-ray illustrates classic radiological findings of acute congestive heart failure. The primary finding is significant cardiomegaly, with the cardiac silhouette appearing enlarged and globular, occupying more than 50% of the thoracic diameter. Diffuse, bilateral hazy opacities are present throughout both lung fields, consistent with pulmonary edema. These opacifications are most prominent in the perihilar regions and lung bases, obscuring normal pulmonary vasculature and the sharp definition of the diaphragmatic borders. The costophrenic angles appear blunted, suggesting associated pleural effusions. Visible medical hardware includes ECG leads positioned on the chest wall. The image serves as an educational example of how chronic heart failure with reduced ejection fraction manifests as pulmonary venous congestion and interstitial-to-alveolar edema on diagnostic imaging.

This diagnostic image is a posterior-anterior (PA) chest x-ray radiography demonstrating significant cardiomegaly and signs of pulmonary congestion. The cardiac silhouette is markedly enlarged, with a transverse diameter exceeding 50% of the thoracic width, suggesting multi-chamber enlargement. The lung fields exhibit diffuse, bilateral increased opacities with perihilar haziness and ill-defined vascular markings, characteristic of interstitial pulmonary edema. Cephalization of the pulmonary vessels is visible, further indicating elevated pulmonary venous pressure. These radiological findings are clinically significant for acute heart failure or decompensated cardiac function, likely secondary to a cardiovascular event such as myocardial infarction. The image serves as an educational example of the visual progression from cardiomegaly to impending acute lung edema in a clinical setting.

This diagnostic image is a posterior-anterior (PA) chest x-ray radiography demonstrating significant cardiomegaly and signs of pulmonary congestion. The cardiac silhouette is markedly enlarged, with a transverse diameter exceeding 50% of the thoracic width, suggesting multi-chamber enlargement. The lung fields exhibit diffuse, bilateral increased opacities with perihilar haziness and ill-defined vascular markings, characteristic of interstitial pulmonary edema. Cephalization of the pulmonary vessels is visible, further indicating elevated pulmonary venous pressure. These radiological findings are clinically significant for acute heart failure or decompensated cardiac function, likely secondary to a cardiovascular event such as myocardial infarction. The image serves as an educational example of the visual progression from cardiomegaly to impending acute lung edema in a clinical setting.

Posteroanterior (PA) view chest X-ray demonstrating clinical features of congestive heart failure and pulmonary edema. The image shows significant cardiomegaly with an enlarged cardiac silhouette. There is evidence of pulmonary venous hypertension, specifically characterized by upper lobe diversion where the vascular markings in the upper lobes are more prominent than those in the lower zones. The hilar regions appear congested with increased density and blurring of the hilar shadows. In the lower lung fields, patchy opacities and areas of increased density are visible, consistent with pulmonary consolidation or alveolar edema. The diaphragmatic angles appear somewhat obscured by the parenchymal density changes. This radiographic presentation is typical for decompensated heart failure, illustrating the redistribution of blood flow and fluid accumulation within the pulmonary parenchyma.

Posteroanterior (PA) view chest X-ray demonstrating clinical features of congestive heart failure and pulmonary edema. The image shows significant cardiomegaly with an enlarged cardiac silhouette. There is evidence of pulmonary venous hypertension, specifically characterized by upper lobe diversion where the vascular markings in the upper lobes are more prominent than those in the lower zones. The hilar regions appear congested with increased density and blurring of the hilar shadows. In the lower lung fields, patchy opacities and areas of increased density are visible, consistent with pulmonary consolidation or alveolar edema. The diaphragmatic angles appear somewhat obscured by the parenchymal density changes. This radiographic presentation is typical for decompensated heart failure, illustrating the redistribution of blood flow and fluid accumulation within the pulmonary parenchyma.

Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Reading File
I now have comprehensive content to compose a full, authoritative answer. Let me compile it:

Congestive Heart Failure (CHF)

Definition

CHF is a clinical syndrome in which cardiac output fails to meet the metabolic demands of the body, leading to fluid congestion in the lungs, periphery, or both. It results from impairment of any of the four primary determinants of cardiac function: preload, contractility, afterload, and heart rate/rhythm. - Rosen's Emergency Medicine, p. 3212

Classification

By Ejection Fraction

TypeEFMechanism
HFrEF (Heart failure with reduced EF)< 40%Systolic dysfunction - impaired contraction
HFmrEF (mildly reduced)40-49%Mixed
HFpEF (preserved EF)≥ 50%Diastolic dysfunction - impaired relaxation/filling

By NYHA Functional Class

ClassDescription
INo symptoms with ordinary activity
IISlight limitation; symptoms with moderate exertion
IIIMarked limitation; symptoms with minimal exertion
IVSymptoms at rest; unable to carry on any activity

Etiology

Common causes in adults:
  • Ischemic heart disease / CAD (most common)
  • Hypertension (hypertensive cardiomyopathy)
  • Valvular heart disease
  • Dilated cardiomyopathy (idiopathic, alcohol, viral myocarditis)
  • Arrhythmias (tachycardia-mediated cardiomyopathy)
  • Thyroid disease (hypo/hyperthyroidism)
  • Diabetes, amyloidosis, hemochromatosis, sarcoidosis
  • Chemotherapy/cardiotoxins
In children: congenital heart disease (CHD) is the primary cause. - Rosen's Emergency Medicine, p. 3212

Pathophysiology

The failing heart triggers compensatory neurohormonal responses:
  1. Sympathetic nervous system activation - Catecholamine release causes vasoconstriction, tachycardia, and increased contractility. Chronically, norepinephrine drives myocyte hypertrophy and apoptosis. - Goldman-Cecil Medicine, p. 3254
  2. RAAS activation - Renin-angiotensin-aldosterone axis causes sodium and water retention, increasing preload and afterload.
  3. Ventricular remodeling - Hypertrophy, dilatation, and fibrosis progressively worsen cardiac function.
  4. Natriuretic peptide release - BNP/ANP are released in response to wall stress; they promote natriuresis and vasodilation (a counter-regulatory response).
These initially compensatory mechanisms become maladaptive over time, creating a self-perpetuating cycle of worsening cardiac function.

Clinical Features

Symptoms

  • Dyspnea on exertion (most common)
  • Orthopnea - dyspnea when lying flat (requires multiple pillows)
  • Paroxysmal nocturnal dyspnea (PND) - awakening with breathlessness
  • Fatigue, weakness
  • Wheezing ("cardiac asthma")
  • Nausea, abdominal distension (right heart failure)

Signs

  • Tachycardia, tachypnea
  • S3 gallop (ventricular filling sound - marker of systolic dysfunction)
  • Crackles/rales at lung bases
  • Elevated JVP (jugular venous pressure)
  • Hepatomegaly (hepatic congestion)
  • Pitting peripheral edema (ankles, legs)
  • Ascites (in severe right heart failure)
  • Displaced apex beat (cardiomegaly)
  • Rosen's Emergency Medicine, p. 3212

Diagnosis

Diagnostic Flowchart

Diagnostic approach to heart failure - Goldman-Cecil Medicine

Key Investigations

1. ECG
  • Assess rhythm, identify ischemia/prior MI
  • Left ventricular hypertrophy (voltage criteria)
  • Bundle branch block (determines eligibility for CRT)
  • Q waves suggest CAD
  • Goldman-Cecil Medicine, p. 2481
2. Chest X-Ray
  • Cardiomegaly (cardiothoracic ratio >50%)
  • Cephalization of pulmonary vessels (upper lobe diversion)
  • Perihilar "bat-wing" pattern (pulmonary edema)
  • Kerley B lines (interstitial edema)
  • Bilateral pleural effusions (often right-sided if unilateral)
CXR showing cardiomegaly and pulmonary congestion in CHF
CXR with upper lobe diversion and pulmonary vascular congestion
3. Natriuretic Peptides (BNP / NT-proBNP)
  • BNP < 100 pg/mL or NT-proBNP < 400 pg/mL makes HF unlikely
  • BNP > 400 pg/mL or NT-proBNP > 125 pg/mL supports the diagnosis
  • BNP between 100-500 pg/mL: indeterminate
  • Also useful for monitoring response to treatment
  • Note: sacubitril (ARNI) increases BNP but NOT NT-proBNP - use NT-proBNP for monitoring in ARNI-treated patients
  • Goldman-Cecil Medicine, p. 2520; Textbook of Family Medicine, p. 777
4. Echocardiography (most important non-invasive test)
  • Measures LVEF (determines HFrEF vs. HFpEF)
  • Identifies wall motion abnormalities, valvular disease, pericardial effusion, cardiomyopathy type
5. Laboratory Tests
  • CBC (detect anemia), BMP (renal function, electrolytes)
  • Glucose, lipid profile, HbA1c
  • TSH (thyroid disease)
  • LFTs (hepatic congestion - elevated transaminases, bilirubin)
  • Serum ferritin/iron studies (hemochromatosis)
  • Consider: HIV, ANA/rheumatologic panel, serum protein electrophoresis (amyloidosis)
  • Goldman-Cecil Medicine, p. 2501

Management

Acute Decompensated Heart Failure

  1. Supplemental oxygen - target SpO2 >94%
  2. CPAP/BiPAP - reduces work of breathing and preload; often averts need for intubation
  3. IV furosemide (loop diuretic) - mainstay for decongestion; 0.5-1 mg/kg in children
  4. IV morphine (cautiously) - reduces preload and anxiety
  5. IV vasodilators (nitrates) - reduce preload and afterload in adults
  6. Inotropes (dobutamine, dopamine) - for cardiogenic shock or low-output states
  7. Intubation and mechanical ventilation if severe respiratory failure

Chronic Management of HFrEF - "4 Pillars"

Current guidelines (based on outcomes evidence) recommend four foundational drug classes:
Drug ClassExamplesStarting DoseTarget Dose
ARNI (preferred over ACEi/ARB)Sacubitril/valsartan24/26 mg twice daily97/103 mg twice daily
ACE Inhibitor (if ARNI not tolerated)Enalapril, Lisinopril, RamiprilLow (e.g., enalapril 2.5 mg BD)Enalapril 10-20 mg BD
ARB (if ACEi not tolerated)Candesartan, Valsartan, LosartanLow dosee.g., Candesartan 32 mg OD
Beta-BlockerBisoprolol, Carvedilol, Metoprolol CR/XL, NebivololLow dose (e.g., bisoprolol 1.25 mg OD)e.g., Bisoprolol 10 mg OD
MRA (mineralocorticoid receptor antagonist)Spironolactone, Eplerenone25 mg OD50 mg OD
SGLT2 inhibitorDapagliflozin, Empagliflozin10 mg OD10 mg OD
  • Goldman-Cecil Medicine, pp. 3147, 3170, 3074-3083
Key principles:
  • Start all drugs at low doses, uptitrate every 2 weeks
  • ACEi/ARB must never be combined with ARNI
  • Wash-out of 36 hours required when switching from ACEi to ARNI
  • Do NOT start beta-blocker during acute decompensation; start only when euvolemic
  • Beta-blocker contraindicated in: asthma, 2nd/3rd degree AV block, HR < 60
  • ARNI contraindicated in: prior angioedema, SBP < 95 mmHg

Diuretics

  • Not mortality-reducing, but essential for symptom relief
  • Furosemide (loop diuretic) - first-line
  • Titrate to achieve euvolemia (dry weight)
  • Monitor electrolytes (hypokalemia, hypomagnesemia) and renal function

Device Therapy

DeviceIndication
ICD (implantable cardioverter-defibrillator)EF ≤ 35%, NYHA II-III, on optimal medical therapy ≥ 3 months
CRT (cardiac resynchronization therapy)EF ≤ 35%, QRS ≥ 150 ms (LBBB morphology), NYHA II-IV
CRT-D (combined CRT + ICD)Meets criteria for both
LVAD (left ventricular assist device)Advanced HF, bridge to transplant or destination therapy
Heart transplantEnd-stage HF refractory to all therapies

Atrial Fibrillation in Heart Failure

AF prevalence ranges from 10% (NYHA I) to 50% (NYHA IV). Rate control with beta-blockers + digoxin is preferred in systolic HF. Amiodarone and dofetilide are the only rhythm-control agents safe in HF. AF catheter ablation improves LVEF, exercise capacity, and survival in HF patients. - Braunwald's Heart Disease, p. 1855

Prognosis

  • 5-year mortality ~50% (worse than many cancers)
  • BNP/NT-proBNP are powerful prognostic markers
  • Elevated hepatic enzymes (congestion), hyponatremia, and renal dysfunction predict poor outcomes
  • Carvedilol is substantially more effective than low-dose short-acting metoprolol for survival
  • Multidisciplinary disease management programs (nurse-led, pharmacist-assisted follow-up) significantly reduce hospitalizations and mortality - PMID 41555291

Summary: NYHA-Guided Approach

  • Class I-II (mild): Start all 4 drug pillars (ARNI/ACEi, beta-blocker, MRA, SGLT2i) + ICD if EF ≤ 35%
  • Class III (moderate): Full 4 pillars + consider CRT if QRS wide; optimize diuretic
  • Class IV (severe): Specialist referral; consider LVAD, transplant listing; beta-blocker with caution
  • Acute decompensation: Diurese to euvolemia, then optimize chronic therapies
Sources: Goldman-Cecil Medicine (International Ed.), Braunwald's Heart Disease (2-Vol Set), Rosen's Emergency Medicine, Murray & Nadel's Respiratory Medicine, Textbook of Family Medicine
This is a shared conversation. Sign in to Orris to start your own chat.